47 results on '"Finetti, Pascal"'
Search Results
2. Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
3. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response
4. TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT
5. Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression
6. BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells
7. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
8. Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
9. LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma
10. Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
11. The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
12. EFA6B regulates a stop signal for collective invasion in breast cancer
13. The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
14. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity
15. Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
16. ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
17. The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
18. Validation and comparison of the molecular classifications of pancreatic carcinomas
19. A 25-gene classifier predicts overall survival in resectable pancreatic cancer
20. Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
21. A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability
22. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer
23. HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
24. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a
25. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer
26. The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy
27. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
28. ESPL1 is a candidate oncogene of luminal B breast cancers
29. Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
30. Djeen (Database for Joomla!’s Extensible Engine): a research information management system for flexible multi-technology project administration
31. ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study
32. Erratum to: Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents
33. Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial
34. Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents
35. Kinome expression profiling and prognosis of basal breast cancers
36. Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis
37. Genome profiling of ERBB2-amplified breast cancers
38. Loss, mutation and deregulation of L3MBTL4 in breast cancers
39. Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
40. A gene expression signature identifies two prognostic subgroups of basal breast cancer
41. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines
42. Nectin-4 is a new histological and serological tumor associated marker for breast cancer
43. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
44. Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling
45. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters
46. Identification and validation of an ERBB2 gene expression signature in breast cancers
47. Genomic Grade Index predicts postoperative clinical outcome of GIST
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.